Eudaimonia Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Eudaimonia Partners’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,000	Closed	–	–	1534
2021 Q1	$0	Buy	+1,000	New	–	﹤0.01%	1684

Eudaimonia Partners's SGYP Position: Q2 2021 in Review

Eudaimonia Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2021, closing a stake of 1,000 shares.

Eudaimonia Partners first reported a position in SGYP in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2021.

Eudaimonia Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 1,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2021.
Eudaimonia Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2021 and held it in 1 quarter.
Eudaimonia Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $0 in Q1 2021.
2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.